.svg){kind=small}
Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Avexia has demonstrated consistent performance across various categories in multiple states, with some noteworthy trends. In Illinois, Avexia maintained a strong presence in the Capsules category, holding a steady second-place ranking from May to August 2025. However, their performance in the Concentrates category experienced some fluctuations, dropping from 11th place in June to 16th in August. Meanwhile, Avexia dominated the Topical category in Illinois, consistently ranking first throughout the same period, a testament to their strong market presence in this segment.
In Maryland, Avexia's performance in the Capsules category mirrored that of Illinois, consistently ranking second from May to August 2025. The Topical category saw a slight dip from first to second place in August, which may warrant closer attention. In New Jersey, Avexia maintained the top spot in the Topical category, but their absence from the top 30 in the Capsules and Tincture & Sublingual categories after June indicates potential challenges in these segments. Meanwhile, in Ohio, Avexia's Tincture & Sublingual category improved its ranking from 5th in May to 3rd in August, suggesting positive momentum in this market.
Competitive Landscape
In the Illinois Topical category, Avexia has consistently maintained its position as the leading brand from May to August 2025, showcasing its dominance in the market. Despite a slight fluctuation in sales figures, Avexia's rank has remained unchallenged, indicating strong brand loyalty and market presence. In contrast, Doctor Solomon's has consistently held the second position, with sales figures significantly lower than Avexia's, suggesting a considerable gap between the two top contenders. Meanwhile, Alchemy (Ieso) appeared in the rankings in May and August, but its absence in June and July highlights a lack of consistent market penetration. These insights underscore Avexia's robust market strategy and its ability to sustain a leading position amidst fluctuating sales and emerging competitors.
Notable Products
In August 2025, the top-performing product from Avexia was the CBD/THC 1:1 Harmony Pain Relief Balm (100mg CBD, 100mg THC, 2oz) in the Topical category, maintaining its number one rank for the fourth consecutive month with sales of 9547 units. The CBD/THC 4:1 Relief Tablets 40-Pack (400mg CBD, 100mg THC) held steady at the second position, consistent since May 2025. Similarly, the CBN/CBD/THC 1:1:1 Comfort Tablets 40-Pack (100mg CBN, 100mg CBD, 100mg THC) remained in third place, showing no change in rank over the months. The CBD/THC 1:1 Harmony Micro-Dosed Tablets 40-Pack (100mg CBD, 100mg THC) improved its position from fifth in May to fourth in June and has remained there since. Lastly, the CBG/THC 1:1 Ascend Tablets 40-Pack (100mg CBG, 100mg THC) experienced a decline from fourth in May to fifth in June, where it has stayed through August.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
